Kessler Topaz Meltzer & Check, LLP Deadline Reminders for Securities Investors
Investors in Cassava Sciences Inc. (SAVA) are being reminded of the upcoming deadline in a securities fraud class action lawsuit. The law firm Kessler Topaz Meltzer & Check, LLP, is alerting investors of the impending deadline to participate in the lawsuit.
The lawsuit alleges that Cassava Sciences Inc. made false and misleading statements regarding its drug candidate for the treatment of Alzheimer’s disease. Specifically, it is claimed that the company misrepresented the results of its clinical trials, leading to an inflated stock price.
Investors who purchased Cassava Sciences Inc. securities between February 2, 2021, and September 5, 2021, are encouraged to participate in the lawsuit before the deadline. The deadline for investors to seek lead plaintiff status is October 26, 2021.
It is essential for investors to be aware of their rights and options in such cases of securities fraud. By participating in the lawsuit, investors have the opportunity to potentially recover financial losses suffered as a result of the alleged fraudulent activities.
If you are an investor in Cassava Sciences Inc. during the specified time period and believe you may have been affected by the alleged securities fraud, it is recommended that you seek legal counsel to discuss your options. Be sure to act promptly, as the deadline for participation in the lawsuit is approaching quickly.
